RxDoctor Payments Data

Alvin Ong, MD

Orthopaedic Surgery · Egg Harbor Township, NJNPI 1992759138

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (39.5%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 63.1% of it on its own, with 16 other manufacturers making up the rest. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$698,708in general payments, 2019–2025

Across 556 payments — averaging $1256.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$441K
  • Stryker$257K
  • Johnson & Johnson$201
  • Zimmer Biomet$174
  • Pacira Pharmaceuticals Incorporated$143
  • BD$129
  • plus $348 from 11 others
$144,832in research payments, 2019–2025

Across 47 payments — averaging $3081.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$111K
  • Smith+Nephew$34K

What the payments were for

  • Royalty or licence$175,64825%
  • Consulting fees$275,86939%
  • Speaking & faculty fees$165,20524%
  • Travel & lodging$68,32910%
  • Food & beverage$13,6572%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$698,708 in reported general payments places this provider in the 95th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$753,479
Medicare patients
921
Services billed
5,624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib173$2,431
Clobetasol EmollientClobetasol Propionate/Emoll23$1,358
Oxycodone Hcl122$897
Clindamycin Hcl248$450
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$310
Cyclobenzaprine Hcl36$267
Prednisone117$216
Methylprednisolone15$82
Tramadol Hcl27$68
Meloxicam28$46
Amoxicillin27$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Egg Harbor Township

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →